Shopping Cart
- Remove All
- Your shopping cart is currently empty
Risevistinel (NYX-783), a positive allosteric modulator of the N-methyl-D-aspartate (NMDA) receptor, may mitigate cognitive deficits in neurodegenerative conditions, including mild cognitive impairment, mild Alzheimer's disease, Parkinson's disease, and Lewy body disease [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | 8-10 weeks | |
50 mg | Inquiry | 8-10 weeks |
Description | Risevistinel (NYX-783), a positive allosteric modulator of the N-methyl-D-aspartate (NMDA) receptor, may mitigate cognitive deficits in neurodegenerative conditions, including mild cognitive impairment, mild Alzheimer's disease, Parkinson's disease, and Lewy body disease [1]. |
Alias | NYX-783 |
Molecular Weight | 297.35 |
Formula | C14H23N3O4 |
Cas No. | 2591344-26-0 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.